172 related articles for article (PubMed ID: 7032872)
1. Trazodone (Desyrel, Mead-Johnson Pharmaceutical Division).
Rawls WN
Drug Intell Clin Pharm; 1982 Jan; 16(1):7-13. PubMed ID: 7032872
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant properties of trazodone.
Bryant SG; Ereshefsky L
Clin Pharm; 1982; 1(5):406-17. PubMed ID: 6764164
[TBL] [Abstract][Full Text] [Related]
3. Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety.
Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1981 Jun; 21(6):401-29. PubMed ID: 7018873
[TBL] [Abstract][Full Text] [Related]
4. Trazodone hydrochloride: a wide spectrum antidepressant with a unique pharmacological profile. A review of its neurochemical effects, pharmacology, clinical efficacy, and toxicology.
Georgotas A; Forsell TL; Mann JJ; Kim M; Gershon S
Pharmacotherapy; 1982; 2(5):255-65. PubMed ID: 6763207
[TBL] [Abstract][Full Text] [Related]
5. Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.
Haria M; Fitton A; McTavish D
Drugs Aging; 1994 Apr; 4(4):331-55. PubMed ID: 8019056
[TBL] [Abstract][Full Text] [Related]
6. Trazodone (Desyrel), a new non-tricyclic antidepressant.
Med Lett Drugs Ther; 1982 May; 24(609):47-8. PubMed ID: 7078519
[No Abstract] [Full Text] [Related]
7. Rediscovering trazodone for the treatment of major depressive disorder.
Fagiolini A; Comandini A; Catena Dell'Osso M; Kasper S
CNS Drugs; 2012 Dec; 26(12):1033-49. PubMed ID: 23192413
[TBL] [Abstract][Full Text] [Related]
8. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
Davis R; Wilde MI
CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
[TBL] [Abstract][Full Text] [Related]
9. Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice.
Cuomo A; Ballerini A; Bruni AC; Decina P; Di Sciascio G; Fiorentini A; Scaglione F; Vampini C; Fagiolini A
Riv Psichiatr; 2019; 54(4):137-149. PubMed ID: 31379379
[TBL] [Abstract][Full Text] [Related]
10. A controlled study of trazodone, imipramine, and placebo in outpatients with endogenous depression.
Mann JJ; Georgotas A; Newton R; Gershon S
J Clin Psychopharmacol; 1981 Mar; 1(2):75-80. PubMed ID: 7028798
[TBL] [Abstract][Full Text] [Related]
11. Trazodone-oral cocaine interactions.
Rowbotham MC; Jones RT; Benowitz NL; Jacob P
Arch Gen Psychiatry; 1984 Sep; 41(9):895-9. PubMed ID: 6380447
[TBL] [Abstract][Full Text] [Related]
12. Trazodone--a new antidepressant.
Al-Yassiri MM; Ankier SI; Bridges PK
Life Sci; 1981 Jun; 28(22):2449-58. PubMed ID: 7019617
[No Abstract] [Full Text] [Related]
13. [Serotonin neurotrasmission and treatment options for depression].
Sivolap YP
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):174-177. PubMed ID: 29265105
[TBL] [Abstract][Full Text] [Related]
14. The electrocardiographic and anticholinergic effects of trazodone and imipramine in man.
Burgess CD; Hames TK; George CF
Eur J Clin Pharmacol; 1982; 23(5):417-21. PubMed ID: 7151845
[TBL] [Abstract][Full Text] [Related]
15. Trazodone. A comparative clinical and predictive study.
Kerr TA; McClelland HA; Stephens DA; Ankier SI
Acta Psychiatr Scand; 1984 Dec; 70(6):573-7. PubMed ID: 6395636
[TBL] [Abstract][Full Text] [Related]
16. Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression.
Hingtgen JN; Hendrie HC; Aprison MH
Pharmacol Biochem Behav; 1984 Mar; 20(3):425-8. PubMed ID: 6608737
[TBL] [Abstract][Full Text] [Related]
17. Overview of USA controlled trials of trazodone in clinical depression.
Feighner JP; Boyer WF
Psychopharmacology (Berl); 1988; 95 Suppl():S50-3. PubMed ID: 3133715
[TBL] [Abstract][Full Text] [Related]
18. Trazodone in depression.
Wheatley D
Int Pharmacopsychiatry; 1980; 15(4):240-6. PubMed ID: 7021449
[TBL] [Abstract][Full Text] [Related]
19. Trazodone in major affective disorders.
Feighner JP
Psychopathology; 1984; 17 Suppl 2():15-23. PubMed ID: 6425917
[TBL] [Abstract][Full Text] [Related]
20. A risk-benefit assessment of mirtazapine in the treatment of depression.
Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
